About this trial
This is a multicenter retrospective observational study aimed to evaluate the prevalence of osteo-metabolic complications in patients with thyroid cancer.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
age ≥ 18 years
Histological diagnosis of Thyroid Carcinoma
radiological data from chest x-ray in lateral projection in the preoperative evaluation on which the vertebral morphometry
Signing of the informed consent
Disqualifiers
Subjects not falling within the previously described criteria are excluded
Trial population
Patients with thyroid cancers who have been evaluated at the outpatient clinics of the Endocrinology Unit of the IRCCS San Raffaele Hospital and the Nuclear Medicine Unit of the Spedali Civili di Brescia.
Trial design
Case-control
Retrospective
Treatments tested in this trial
Diagnostic (chest x-ray /DXA)and clinical data collected for clinical practice
Diagnostic testBiochemical, clinical and radiological data performed for clinical practice will be retrospectively collected. Osteoporosis and vertebral fractures will be diagnosed through DXA scan and vertebral morphometry.
Treatment groups
Trial outcomes
Primary outcomes
To estimate the incidence and prevalence of osteoporosis and vertebral fractures in Patients With Thyroid Cancer
To estimate the incidence and prevalence of osteoporosis and vertebral fractures detected through DXA scan and vertebral morphometry. The effects on bone complications of the patients' clinical and biochemical characteristics will be investigated.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
IRCCS San Raffaele
Lead sponsor
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Collaborator